Cambridge Investment Research Advisors, Inc. - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 27 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2021$27,000
-3.6%
10,0000.0%0.00%
Q2 2021$28,000
-6.7%
10,0000.0%0.00%
Q1 2021$30,0000.0%10,0000.0%0.00%
Q4 2020$30,000
-6.2%
10,0000.0%0.00%
Q3 2020$32,000
-3.0%
10,0000.0%0.00%
Q2 2020$33,000
-8.3%
10,0000.0%0.00%
Q1 2020$36,000
-30.8%
10,0000.0%0.00%
Q4 2019$52,000
-11.9%
10,0000.0%0.00%
-100.0%
Q3 2019$59,000
-7.8%
10,0000.0%0.00%0.0%
Q2 2019$64,000
+10.3%
10,0000.0%0.00%0.0%
Q1 2019$58,000
-3.3%
10,0000.0%0.00%0.0%
Q4 2018$60,000
+5.3%
10,0000.0%0.00%0.0%
Q3 2018$57,000
-6.6%
10,0000.0%0.00%0.0%
Q2 2018$61,000
-9.0%
10,0000.0%0.00%0.0%
Q1 2018$67,000
-9.5%
10,0000.0%0.00%0.0%
Q4 2017$74,000
+4.2%
10,0000.0%0.00%0.0%
Q3 2017$71,000
+1.4%
10,0000.0%0.00%0.0%
Q2 2017$70,000
+1.4%
10,0000.0%0.00%0.0%
Q1 2017$69,000
+25.5%
10,0000.0%0.00%0.0%
Q4 2016$55,000
+10.0%
10,0000.0%0.00%0.0%
Q3 2016$50,000
+11.1%
10,0000.0%0.00%0.0%
Q2 2016$45,0000.0%10,0000.0%0.00%0.0%
Q1 2016$45,000
-15.1%
10,0000.0%0.00%0.0%
Q4 2015$53,000
-8.6%
10,0000.0%0.00%
-50.0%
Q3 2015$58,000
-19.4%
10,0000.0%0.00%0.0%
Q2 2015$72,000
+7.5%
10,0000.0%0.00%0.0%
Q1 2015$67,000
+11.7%
10,0000.0%0.00%0.0%
Q4 2014$60,000
+22.4%
10,0000.0%0.00%
+100.0%
Q3 2014$49,000
+8.9%
10,0000.0%0.00%
-50.0%
Q2 2014$45,00010,0000.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q1 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 739,917$5,135,0002.89%
JW Asset Management, LLC 263,881$1,830,0000.38%
BARD ASSOCIATES INC 442,825$3,075,0000.29%
Ariel Investments 1,393,125$9,668,0000.11%
TFS CAPITAL LLC 11,499$80,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 293,700$2,038,0000.02%
DELTA ASSET MANAGEMENT LLC/TN 12,000$83,0000.01%
ESSEX INVESTMENT MANAGEMENT CO LLC 10,945$76,0000.01%
EAGLE GLOBAL ADVISORS LLC 52,767$366,0000.01%
Spark Investment Management LLC 22,600$156,0000.01%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders